Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 16714-980

7 FDA label images from Northstar Rx Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 16714-980). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
Chemical structure diagram of esomeprazole magnesium with indicated magnesium ion and water molecules.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A line chart showing the percentage maintained over 6 months for Esomeprazole Magnesium capsules in 20 mg and 40 mg strengths, compared with 10 mg Esomeprazole and placebo groups. The vertical axis represents percent maintained, and the horizontal axis represents time in months. The 40 mg and 20 mg groups maintain a higher percentage over time compared to the 10 mg and placebo groups.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A line graph depicting the percent of a measured parameter maintained over six months for Esomeprazole Magnesium at 20 mg and 40 mg strengths, compared with placebo and an additional 10 mg dose. The y-axis represents percent maintained, and the x-axis represents months, showing trends for each group over time.*
FDA Label Image

Figure4 (Figure4)

Figure4 (Figure4)
A line graph comparing the percentage of patients pain-free over a 28-day diary period for Esomeprazole 40 mg, Esomeprazole 20 mg, and a placebo. The x-axis represents diary days from 0 to 28, while the y-axis shows the percent of patients pain-free from 0 to 100%. Three lines depict the performance of each treatment group over time.*
FDA Label Image

Figure5 (Figure5)

Figure5 (Figure5)
A line graph depicting the percent of patients symptom-free over a 28-day diary period. The graph compares three groups: Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo, showing trends in symptom relief over time.*
FDA Label Image

Container1 (Container1)

Container1 (Container1)
Label for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg, supplied in a bottle of 90 capsules. The label includes dosage information, storage instructions, and manufacturer details, stating the product is made by Dr. Reddy's Laboratories Limited and labeled by NorthStar Rx LLC. The label also features the NDC 16714-979-02 and a barcode.*
FDA Label Image

Container2 (Container2)

Container2 (Container2)
Label for Esomeprazole Magnesium Delayed-Release Capsules USP 40 mg by NorthStar Rx LLC. The label states it contains 90 capsules and includes NDC 16714-980-02. Manufacturer details show packaging by Dr. Reddy's Laboratories Limited in India. The label features instructions to dispense a medication guide to each patient and storage conditions of 20° to 25°C.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.